| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1517/14656566.1.2.305 |
| P698 | PubMed publication ID | 11249551 |
| P2093 | author name string | B C Lund | |
| P J Perry | |||
| P2860 | cites work | A rating scale for drug-induced akathisia | Q28258433 |
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| Agranulocytosis during treatment with chlozapine | Q33495240 | ||
| Olanzapine in treatment-resistant bipolar disorder | Q42678439 | ||
| Radioreceptor binding profile of the atypical antipsychotic olanzapine | Q49130929 | ||
| The reliability of distinguishing primary versus secondary negative symptoms. | Q52012630 | ||
| Newer antipsychotics in treatment-resistant schizophrenia. | Q52909500 | ||
| Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. | Q53929198 | ||
| An open trial of olanzapine in patients with treatment-refractory psychoses. | Q53937781 | ||
| Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports | Q58185825 | ||
| Olanzapine-Induced Weight Gain | Q58276740 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 305-323 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Olanzapine: an atypical antipsychotic for schizophrenia | |
| P478 | volume | 1 |
| Q43167835 | Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients |
| Q44007035 | Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection |
| Q45052998 | Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile |
| Q38246661 | The potential role of atypical antipsychotics in the treatment of panic disorder |
Search more.